Efficacy and safety of Kaisimen needle for Yang deficiency Chronic fatigue syndrome

Efficacy and safety of Kaisimen needle for Yang deficiency Chronic fatigue syndrome based on energy metabolism

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ITMCTR

Registry ID

ITMCTR2200005696

Enrollment

Unknown

Registered

2022-03-12

Start date

2022-03-15

Completion date

Unknown

Last updated

2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic fatigue syndrome

Interventions

acupuncture group:acupuncture

Kaisimen group:Kaisimen needle+ acupuncture

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: ? Meet the diagnostic criteria of Yang deficiency chronic fatigue syndrome; ? The age is between 18 and 60 years old; ? Normal thinking, able to communicate in language; ? Voluntarily sign informed consent.

Exclusion criteria

Exclusion criteria: ? Patients with some causes affecting chronic fatigue; ? Combined with other serious heart, brain, kidney diseases and mental disorders; ? Pregnant and lactating women, and women having pregnancy requirements in recent half a year; ? Patients who have received the treatment of chronic fatigue syndrome in recent three months, such as traditional Chinese medicine, acupuncture and Western medicine; ? Patients who are undergoing other clinical trials.

Design outcomes

Primary

Measure	Time frame
Fatigue Scale-14;	—

Secondary

Measure	Time frame
the 12-items Short Form Health Survey;adverse event rate;Infrared thermal imaging;Yang deficiency syndrome scale;	—

Countries

China

Contacts

Public ContactZHU Deliang

369086069@qq.com18030616855

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026